Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 7
Submit an article Journal homepage
79
Views
7
CrossRef citations to date
0
Altmetric
Original

Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma

Muzaffar H. Qazilbash Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
,
Rima M. Saliba Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USA
,
Ana Aleman Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USA
,
X. Lei Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USA
,
Donna Weber Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USA
,
Antonio Carrasco Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USA
,
Richard E. Champlin Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USA
&
Sergio A. Giralt Department of Blood and Marrow Transplantation UT-MD Anderson Cancer Center, Houston, TX, USA
 show all
Pages 1360-1364 | Received 14 Jun 2005, Accepted 11 Nov 2005, Published online: 01 Jul 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hong Liu, Constance Yuan, Jeremy Heinerich, Raul Braylan, Myron Chang, John Wingard & Jan Moreb. (2008) Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: A retrospective study. Leukemia & Lymphoma 49:2, pages 306-314.
Read now

Articles from other publishers (6)

Zhiqiang Liu, Jingda Xu, Jin He, Huan Liu, Pei Lin, Xinhai Wan, Nora M. Navone, Qiang Tong, Larry W. Kwak, Robert Z. Orlowski & Jing Yang. (2015) Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget 6:33, pages 34329-34341.
Crossref
S M A Kazmi, R M Saliba, M Donato, M Wang, C Hosing, S Qureshi, P Anderlini, U Popat, R E Champlin, S A Giralt & M H Qazilbash. (2010) Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma. Bone Marrow Transplantation 46:4, pages 510-515.
Crossref
Muzaffar H. Qazilbash, Rima M. Saliba, Yago Nieto, Gaurav Parikh, Matteo Pelosini, Fatima B. Khan, Roy B. Jones, Chitra Hosing, Floralyn Mendoza, Donna M. Weber, Michael Wang, Uday Popat, Amin Alousi, Paolo Anderlini, Richard E. Champlin & Sergio Giralt. (2008) Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial. Biology of Blood and Marrow Transplantation 14:12, pages 1401-1407.
Crossref
David Dingli, Jorge M. Pacheco, Grzegorz S. Nowakowski, Shaji K. Kumar, Angela Dispenzieri, Suzanne R. Hayman, Martha Q. Lacy, Dennis A. Gastineau & Morie A. Gertz. (2007) Relationship Between Depth of Response and Outcome in Multiple Myeloma. Journal of Clinical Oncology 25:31, pages 4933-4937.
Crossref
Muzaffar H. Qazilbash, Rima M. Saliba, Bilal Ahmed, Gaurav Parikh, Floralyn Mendoza, Noman Ashraf, Chitra Hosing, Thuy Flosser, Donna M. Weber, Michael Wang, Daniel R. Couriel, Uday Popat, Partow Kebriaei, Amin M. Alousi, Paolo Anderlini, Rizwan C. Naeem, Richard E. Champlin & Sergio A. Giralt. (2007) Deletion of the Short Arm of Chromosome 1 (del 1p) is a Strong Predictor of Poor Outcome in Myeloma Patients Undergoing an Autotransplant. Biology of Blood and Marrow Transplantation 13:9, pages 1066-1072.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.